(S)-(+)-Ibuprofen, 99%, Thermo Scientific Chemicals

Element Search

Structure Search

Thermo Scientific Chemicals

(S)-(+)-Ibuprofen, 99%, Thermo Scientific Chemicals

Name: (S)-(+)-Ibuprofen, 99%, Thermo Scientific Chemicals
SKU: 333200010

(S)-(+)-Ibuprofen, CAS # 51146-56-6, is the active enantomerof the non-steroidal anti-inflammatory drug, ibuprofen.

Change view

Quantity:

Packaging:

Glass bottle

Try the chem dex^TM web app

Catalog number 333200010

Price (TWD)/ Each

Request A Quote

Quantity:

Packaging:

Glass bottle

Request bulk or custom format

Chemical Identifiers

CAS51146-56-6

IUPAC Name(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid

Molecular FormulaC13H18O2

InChI KeyHEFNNWSXXWATRW-JTQLQIEISA-N

SMILESCC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O

Specifications

Specification Sheet

Infrared spectrumConforms

Melting point49°C to 53°C

Appearance (Form)Crystalline powder or crystals

GC>=98.5 %

Specific optical rotation+57° to +61° (20°C, 589 nm) (c=2, EtOH)

This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

Ibuprofen is a nonsteroidal anti-inflammatory drug commonly used in its racemic form

(S)-(+)-Ibuprofen is the active enantiomer of this drug that confers anti-inflammatory activity

(S)-(+)-Ibuprofen inhibits prostaglandin synthesis and thus reduces inflammation and pain when ingested

Applications

As the active enantiomer of ibuprofen, (S)-(+)-Ibuprofen is used in laboratory research for pharmacokinetic studies

(S)-(+)-Ibuprofen may be used as an inhibitor of cycloogenase 1 and 2 and an agonist of PPARalpha and PPARgamma

(S)-(+)-Ibuprofen may be used as material to study development of drug delivery systems

RUO – Research Use Only

References

Kato, M.; Nishida, S.; Kitasato, H.; Sakata, N.; Kawai, S. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001, 53(12), 1679-85.

Davies, N.M. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998, 34(2), 101-54.

Jaradat, M.S.; Wongsud, B.; Phornchirasilp, S.; Rangwala, S.M.; Shams, G.; Sutton, M.; Romstedt, K.J.; Noonan, D.J.; Feller, D.R. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. Biochem Pharmacol. 2001, 62(12), 1587-95.

Irvine, J.; Afrose, A.; Islam, N. Formulation and delivery strategies of ibuprofen: challenges and opportunities. Drug Dev Ind Pharm. 2018, 44(2), 173-183.